Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Mar 9:9:37-47.
doi: 10.4137/CMPed.S17841. eCollection 2015.

Normal Growth of Healthy Infants Born from HIV+ Mothers Fed a Reduced Protein Infant Formula Containing the Prebiotics Galacto-Oligosaccharides and Fructo-Oligosaccharides: A Randomized Controlled Trial

Affiliations

Normal Growth of Healthy Infants Born from HIV+ Mothers Fed a Reduced Protein Infant Formula Containing the Prebiotics Galacto-Oligosaccharides and Fructo-Oligosaccharides: A Randomized Controlled Trial

Hugo da Costa Ribeiro Júnior et al. Clin Med Insights Pediatr. .

Abstract

Objective: The aim of the current study was to evaluate the safety of a new reduced protein (2.1 g/100 kcal) infant formula containing 4 g/L of 90% galacto-oligosaccharides (GOS) and 10% fructo-oligosaccharides (FOS).

Methods: Healthy term infants from Brazil were enrolled. Those born to human immunodeficiency virus (HIV)-positive mothers were randomized to a test (n = 65) or control (n = 63) formula group. Infants born to HIV-negative mothers were either exclusively breast-fed (n = 79) or received a mixed diet (breast milk and test formula, n = 65). Between 2 weeks and 4 months of age, infants were exclusively fed according to their assigned group. Anthropometric measurements were taken at baseline, 1, 2, 3, 4, 6, 8, 10, and 12 months. Digestive tolerance was evaluated during the first 4 months. The primary outcome was mean daily weight gain between 2 weeks and 4 months in the test formula and breast-fed groups.

Results: Data from all infants (N = 272) were used in the intention-to-treat (ITT) analysis and data from 230 infants were used in the per-protocol (PP) analysis. The difference in mean daily weight gain between 2 weeks and 4 months in the test formula and breast-fed groups was 1.257 g/day (one-sided 95% confidence interval [CI]: -0.705 to inf, P < 0.001) in the PP analysis, showing that the lower bound of the 95% CI was above the -3.0 g/day non-inferiority margin. Results were similar in the ITT analysis. Symptoms of digestive tolerance and frequency of adverse events were similar in the two groups.

Conclusions: The formula containing 2.1 g/100 kcal protein and GOS and FOS was safe and tolerated well.

Keywords: fructo-oligosaccharides; galacto-oligosaccharides; infant formula; safety; weight gain.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow of infants participating in the study. Abbreviations: ITT, intention-to-treat; PP, per protocol; LTFU, loss to follow-up; SAE, serious adverse event.
Figure 2
Figure 2
Mean volume of formula intake during the exclusive feeding period, intention-to-treat (test formula, n = 65 and control formula, n = 63). Error bars indicate standard deviation. There were no significant differences between groups (analysis of covariance adjusted for birth weight P > 0.1 at all time points).
Figure 3
Figure 3
Mean anthropometric measurements relative to World Health Organization child growth standards, intention-to-treat. (A) Weight-for-age z-scores, (B) length-for-age z-scores, (C) body mass index (BMI)-for-age z-scores, (D) head circumference-for-age z-scores.
Figure 3
Figure 3
Mean anthropometric measurements relative to World Health Organization child growth standards, intention-to-treat. (A) Weight-for-age z-scores, (B) length-for-age z-scores, (C) body mass index (BMI)-for-age z-scores, (D) head circumference-for-age z-scores.
Figure 4
Figure 4
Stool consistency, intention-to-treat. The proportion of days with predominant stool consistencies is shown. Significant differences (Dunnett test, P < 0.05, adjusted by the Hommel method) between the test formula and the other groups are shown by an asterisk (*).

References

    1. Lonnerdal B. Nutritional and physiologic significance of human milk proteins. Am J Clin Nutr. 2003;77(6):1537S–43S. - PubMed
    1. Mace K, Steenhout P, Klassen P, Donnet A. Protein quality and quantity in cow’s milk-based formula for healthy term infants: past, present and future. Nestle Nutr Workshop Ser Pediatr Program. 2006;58:189–203. discussion 203–185. - PubMed
    1. Räihä NC, Fazzolari-Nesci A, Cajozzo C, et al. Whey predominant, whey modified infant formula with protein/energy ratio of 1.8 g/100 kcal: adequate and safe for term infants from birth to four months. J Pediatr Gastroenterol Nutr. 2002;35(3):275–81. - PubMed
    1. Ziegler EE. Protein requirements in infancy. Infant formula: closer to the reference. In: Räihä N, Rubaltelli FF, editors. Nestlé Nutrition Workshop Series. Supplement Vol. 47. Philadelphia: Williams & Wilkins; 2002. pp. 97–110.
    1. Ziegler EE, Jeter JM, Drulis JM, Nelson SE, Haschke F, Steenhout P. Formula with reduced content of improved, partially hydrolyzed protein and probiotics: infant growth and health. Monatsschr Kinderheilkd. 2003;151:S65–71.

LinkOut - more resources